Accuri C6 Flow Cytometer System
A more recent version of this article appeared on June 1, 2005

Published online before print March 17, 2005
This Article
Right arrow Full Text (Reprint (PDF))
Right arrow All Versions of this Article:
jlb.1104652v1
77/6/966    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaplan, B. L. F.
Right arrow Articles by Kaminski, N. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaplan, B. L. F.
Right arrow Articles by Kaminski, N. E.
© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.1104652


Received for publication November 10, 2004.
Revised January 26, 2005.
Accepted for publication February 14, 2005.


Article

2-Arachidonoyl-glycerol suppresses interferon-{gamma} production in phorbol ester/ionomycin-activated mouse splenoctyes independent of CB1 or CB2

Barbara L. F. Kaplan , Yanli Ouyang , Cheryl E. Rockwell , Gautham K. Rao , and Norbert E. Kaminski @

Department of Pharmacology and Toxicology and Center for Integrative Toxicology, Michigan State University, East Lansing

@ To whom correspondence should be addressed. E-mail: kamins11{at}msu.edu.


arrow
Abstract

2-Arachidonoyl-glycerol (2-AG), an endogenous ligand for cannabinoid receptor types 1 and 2 (CB1 and CB2), has previously been demonstrated to modulate immune functions including suppression of interleukin-2 expression and nuclear factor of activated T cells (NFAT) activity. The objective of the present studies was to investigate the effect of 2-AG on interferon-{gamma} (IFN-{gamma}) expression and associated upstream signaling events. Pretreatment of splenocytes with 2-AG markedly suppressed phorbol 12-myristate 13-acetate plus calcium ionophore (PMA/Io)-induced IFN-{gamma} secretion. In addition, 2-AG suppressed IFN-{gamma} steady-state mRNA expression in a concentration-dependent manner. To unequivocally determine the putative involvement of CB1 and CB2, splenocytes derived from CB1-/-/CB2-/- knockout mice were used. No difference in the magnitude of IFN-{gamma} suppression by 2-AG in wild-type versus CB1/CB2 null mice was observed. Time-of-addition studies revealed that 2-AG treatment up to 12 h post-cellular activation resulted in suppression of IFN-{gamma}, which was consistent with a time course conducted with cyclosporin A, an inhibitor of NFAT activity. Coincidentally, 2-AG perturbed the nuclear translocation of NFAT protein and blocked thapsigargin-induced elevation in intracellular calcium, suggesting that altered calcium regulation might partly explain the suppression of NFAT nuclear translocation and subsequent IFN-{gamma} production. Indeed, Io partially attenuated the 2-AG-induced suppression of PMA/Io-stimulated IFN-{gamma} production. Taken together, these data demonstrate that 2-AG suppresses IFN-{gamma} expression in murine splenocytes in a CB-independent manner and that the mechanism partially involves suppression of intracellular calcium signaling and perturbation of NFAT nuclear translocation.

Key Words: cannabinoid • nuclear factor of activated T cells




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
J. P. Buchweitz, P. W. F. Karmaus, K. J. Williams, J. R. Harkema, and N. E. Kaminski
Targeted deletion of cannabinoid receptors CB1 and CB2 produced enhanced inflammatory responses to influenza A/PR/8/34 in the absence and presence of {Delta}9-tetrahydrocannabinol
J. Leukoc. Biol., March 1, 2008; 83(3): 785 - 796.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Raduner, A. Majewska, J.-Z. Chen, X.-Q. Xie, J. Hamon, B. Faller, K.-H. Altmann, and J. Gertsch
Alkylamides from Echinacea Are a New Class of Cannabinomimetics: CANNABINOID TYPE 2 RECEPTOR-DEPENDENT AND -INDEPENDENT IMMUNOMODULATORY EFFECTS
J. Biol. Chem., May 19, 2006; 281(20): 14192 - 14206.
[Abstract] [Full Text] [PDF]